Print

Conatus Pharmaceuticals Inc. to Report Third Quarter 2013 Financial Results on November 14, 2013  
11/8/2013 9:12:27 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO, Nov. 7, 2013 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced that it will report financial results for the third quarter ended September 30, 2013 on Thursday, November 14, 2013. Conatus's management team will host a conference call and audio webcast at 4:30 p.m. Eastern Time on Thursday, November 14, 2013 to discuss the quarterly results and provide a corporate update.

Help employers find you! Check out all the jobs and post your resume.

//-->